AN OVERVIEW:

WHY MEDICAL ACCOUNTS RECEIVABLE (MAR) FUNDING?

Working Capital: all healthcare executives need it…to keep up with changing medical technology…expand facilities…purchase new equipment…invest in additional personnel…or in some cases, ensure the financial survival of healthcare providers and suppliers.

With new HIPAA mandates, more stringent regulatory policies, falling reimbursements, and ever-rising costs, while at the same time payments are lagging, more and more healthcare executives are looking for strategic innovative ways to generate working capital and improve their bottom line.

Whether in expansion mode or financial stress, working within the ever-changing healthcare environment is fiscally challenging.

The Challenges:

Today’s healthcare providers are faced with a growing number of challenges that include:

• Solving daily working capital needs
• Burgeoning population of aging baby boomers that will confront all providers.
• Reduced payments
• Spiraling practice costs
• Denials from payors
• Scarcity of healthcare professionals
• Changing technology
• Electronic medical records
• Increasing patient demands

Regulatory intervention and restrictive banking policies create additional obstacles to meeting these challenges.

The Solution:

A rapid, simple and proven successful working capital strategy includes Medical Accounts Receivable [MAR] funding, which provides a debt-free and predictable cash flow when you need it…a type of immediate and unrestricted funding that can only be utilized through a very specialized financial services company.

Sun Capital HealthCare, Inc.’s (SCH) medical accounts receivable funding programs are exclusively targeted to the healthcare industry. Providers use the cash infusion derived from medical accounts receivable funding as unrestricted working capital for business growth, acquisitions, equipment purchases and debt refinancing. SCH’s knowledge of healthcare, third-party reimbursement, and healthcare finance delivers to clients superior value-added funding solutions.

In addition to providing funds for growth and expansion for a wide spectrum of healthcare providers, SCH and its MAR Funding programs have successfully assisted beleaguered providers to avoid pending bankruptcy. In some cases, SCH has set new judicial and legal precedents for innovative post-petition bankruptcy funding so that medical facilities and practices can continue without interruption in service to their patients as they work through reorganization.

Accounts receivable funding is a multi-trillion dollar financial industry that provides cash infusion to a wide variety of businesses of all sizes, including Fortune 500 companies. Sun Capital is a leading financial resource within this specialized funding niche.

WHAT IS MEDICAL ACCOUNTS RECEIVABLE (MAR) FUNDING?

MAR funding is accounts receivable funding customized for healthcare providers. By purchasing a provider’s or supplier’s accounts receivable, SCH transforms cash flow into a solution for generating working capital rather than an obstacle to growth and profitability. Providers use the cash infusion derived from medical accounts receivable funding as unrestricted working capital for business growth, acquisitions, equipment purchases and debt refinancing.

At SCH, providers usually receive cash within 24-48 hours of submission of claims. We offer medical accounts receivable funding for healthcare clients whose funding needs range upward from $50,000 net collectable value.

Those poised to benefit most include: